Graeme Preston

728 total citations
20 papers, 354 citations indexed

About

Graeme Preston is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, Graeme Preston has authored 20 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Physiology. Recurrent topics in Graeme Preston's work include Glycosylation and Glycoproteins Research (4 papers), Renal and related cancers (4 papers) and Birth, Development, and Health (3 papers). Graeme Preston is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Renal and related cancers (4 papers) and Birth, Development, and Health (3 papers). Graeme Preston collaborates with scholars based in United States, Hungary and Netherlands. Graeme Preston's co-authors include Renfang Song, Ihor V. Yosypiv, Tamás Kozicz, Éva Morava, Atsuhiro Ichihara, Tim L. Emmerzaal, John V. Moran, Sangeetha Iyer, Prescott L. Deininger and Nina DiPrimio and has published in prestigious journals such as PLoS ONE, Developmental Biology and Gene.

In The Last Decade

Graeme Preston

19 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graeme Preston United States 12 224 66 57 53 51 20 354
Shasha Zhang China 9 119 0.5× 18 0.3× 15 0.3× 27 0.5× 36 0.7× 22 262
Mallikarjuna R. Guruju United States 8 203 0.9× 130 2.0× 13 0.2× 46 0.9× 77 1.5× 10 448
Iêda de Fátima Oliveira Silva Brazil 13 79 0.4× 20 0.3× 16 0.3× 26 0.5× 35 0.7× 29 393
Hedvig Bennet Sweden 11 206 0.9× 30 0.5× 23 0.4× 193 3.6× 175 3.4× 15 546
David Lau United States 13 119 0.5× 53 0.8× 21 0.4× 46 0.9× 57 1.1× 20 422
João Vaz‐Silva Portugal 7 101 0.5× 28 0.4× 16 0.3× 14 0.3× 27 0.5× 10 409
Noriko Togashi Japan 12 154 0.7× 42 0.6× 70 1.2× 86 1.6× 58 1.1× 42 436
Bin Cong China 11 289 1.3× 48 0.7× 17 0.3× 35 0.7× 13 0.3× 35 416
Monica A. Millan United States 6 119 0.5× 145 2.2× 55 1.0× 18 0.3× 204 4.0× 7 447

Countries citing papers authored by Graeme Preston

Since Specialization
Citations

This map shows the geographic impact of Graeme Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme Preston more than expected).

Fields of papers citing papers by Graeme Preston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme Preston. The network helps show where Graeme Preston may publish in the future.

Co-authorship network of co-authors of Graeme Preston

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme Preston. A scholar is included among the top collaborators of Graeme Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme Preston. Graeme Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ranatunga, Wasantha, Graeme Preston, Ethan Perlstein, et al.. (2024). N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts. Glycobiology. 34(11). 2 indexed citations
3.
Ligezka, Anna N., Gina L. Mazza, Graeme Preston, et al.. (2023). Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylation. Molecular Genetics and Metabolism. 139(2). 107606–107606. 8 indexed citations
4.
Ligezka, Anna N., Fabienne C. Fiesel, Graeme Preston, et al.. (2023). Interplay of Impaired Cellular Bioenergetics and Autophagy in PMM2-CDG. Genes. 14(8). 1585–1585. 11 indexed citations
5.
Balakrishnan, Bijina, Ruqaiah Altassan, Willisa Liou, et al.. (2023). AAV-based gene therapy prevents and halts the progression of dilated cardiomyopathy in a mouse model of phosphoglucomutase 1 deficiency (PGM1-CDG). Translational research. 257. 1–14. 12 indexed citations
6.
Johnsen, Christin, Seul Kee Byeon, Wasantha Ranatunga, et al.. (2022). TRIT1 defect leads to a recognizable phenotype of myoclonic epilepsy, speech delay, strabismus, progressive spasticity, and normal lactate levels. Journal of Inherited Metabolic Disease. 45(6). 1039–1047. 8 indexed citations
7.
Radenkovic, Silvia, Diego Martinelli, Yuebo Zhang, et al.. (2022). TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disability. Genetics in Medicine. 24(4). 894–904. 13 indexed citations
8.
Preston, Graeme, Tim L. Emmerzaal, Silvia Radenkovic, et al.. (2021). Cerebellar and multi-system metabolic reprogramming associated with trauma exposure and post-traumatic stress disorder (PTSD)-like behavior in mice. Neurobiology of Stress. 14. 100300–100300. 9 indexed citations
9.
Emmerzaal, Tim L., Graeme Preston, Bram Geenen, et al.. (2020). Impaired mitochondrial complex I function as a candidate driver in the biological stress response and a concomitant stress-induced brain metabolic reprogramming in male mice. Translational Psychiatry. 10(1). 176–176. 35 indexed citations
10.
11.
Preston, Graeme, Tim L. Emmerzaal, Laura A. Schrader, et al.. (2020). Cerebellar mitochondrial dysfunction and concomitant multi-system fatty acid oxidation defects are sufficient to discriminate PTSD-like and resilient male mice. Brain Behavior & Immunity - Health. 6. 100104–100104. 14 indexed citations
12.
Iyer, Sangeetha, Nina DiPrimio, Graeme Preston, et al.. (2019). Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG. Disease Models & Mechanisms. 12(11). 44 indexed citations
13.
Preston, Graeme, et al.. (2018). The role of suboptimal mitochondrial function in vulnerability to post‐traumatic stress disorder. Journal of Inherited Metabolic Disease. 41(4). 585–596. 27 indexed citations
14.
Song, Renfang, Graeme Preston, Daniel Bushnell, et al.. (2015). Prorenin receptor is critical for nephron progenitors. Developmental Biology. 409(2). 382–391. 21 indexed citations
15.
Song, Renfang, Graeme Preston, & Ihor V. Yosypiv. (2013). Ontogeny of the (pro)renin receptor. Pediatric Research. 74(1). 5–10. 9 indexed citations
16.
Song, Renfang, Graeme Preston, Atsuhiro Ichihara, & Ihor V. Yosypiv. (2013). Deletion of the Prorenin Receptor from the Ureteric Bud Causes Renal Hypodysplasia. PLoS ONE. 8(5). e63835–e63835. 46 indexed citations
17.
Song, Renfang, et al.. (2012). Angiotensin II regulates growth of the developing papillas ex vivo. American Journal of Physiology-Renal Physiology. 302(9). F1112–F1120. 10 indexed citations
18.
Song, Renfang, Graeme Preston, & Ihor V. Yosypiv. (2011). Angiotensin II stimulates in vitro branching morphogenesis of the isolated ureteric bud. Mechanisms of Development. 128(7-10). 359–367. 16 indexed citations
19.
Song, Renfang, Graeme Preston, & Ihor V. Yosypiv. (2011). Ontogeny of angiotensin-converting enzyme 2. Pediatric Research. 71(1). 13–19. 38 indexed citations
20.
Gasior, Stephen L., Graeme Preston, Dale J. Hedges, et al.. (2006). Characterization of pre-insertion loci of de novo L1 insertions. Gene. 390(1-2). 190–198. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shasha Zhang Breakdown of academic impact, for papers by Mallikarjuna R. Guruju Breakdown of academic impact, for papers by Iêda de Fátima Oliveira Silva Breakdown of academic impact, for papers by Hedvig Bennet Breakdown of academic impact, for papers by David Lau Breakdown of academic impact, for papers by João Vaz‐Silva Breakdown of academic impact, for papers by Noriko Togashi Breakdown of academic impact, for papers by Bin Cong Breakdown of academic impact, for papers by Monica A. Millan
Rankless by CCL
2026